Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2020 08:45 ET | Source: Cambrex Corporation

Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility

EAST RUTHERFORD, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle,...
March 31, 2020 08:00 ET | Source: Cambrex Corporation

Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit

EAST RUTHERFORD, N.J., March 31, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle,...
January 06, 2020 11:36 ET | Source: Cambrex Corporation

Cambrex Announces Management Changes and Board Appointments

EAST RUTHERFORD, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug...
December 04, 2019 09:27 ET | Source: Cambrex Corporation

Cambrex Announces Completion of Acquisition by the Permira Funds

EAST RUTHERFORD, N.J., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
November 14, 2019 07:30 ET | Source: Cambrex Corporation

Cambrex Wins Third API Development Award at CPhI Worldwide

EAST RUTHERFORD, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
October 24, 2019 06:40 ET | Source: Cambrex Corporation

Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results

EAST RUTHERFORD, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
September 23, 2019 06:40 ET | Source: Cambrex Corporation

Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement

EAST RUTHERFORD, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) (the “Company” or “Cambrex”) today announced the expiration, as of 12:01 a.m., Eastern Time, on September...
August 07, 2019 12:55 ET | Source: Cambrex Corporation

Cambrex Cancels Second Quarter Earnings Conference Call and Will Not Update Financial Guidance

EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
August 07, 2019 06:30 ET | Source: Cambrex Corporation

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash

EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
August 06, 2019 10:10 ET | Source: Cambrex Corporation

Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019

EAST RUTHERFORD, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...